Agents | Mechanism of action | Administration | Main side effects | State |
---|---|---|---|---|
Abciximab | inhibit GPIIb/IIIa receptor and GP αIIb/β3 receptor | IV | allergy, bleeding, thrombocytopenia | Approved |
Eptifibatide | inhibit GPIIb/IIIa receptor | IV | bleeding, thrombocytopenia | Approved |
Tirofiban | inhibit GP IIb/IIIa receptor | IV | bleeding, thrombocytopenia | approved |